This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Sep 24 at 11:56 AMMGEE+2.29%ARES+1.58%
Turn Therapeutics Inc. (NASDAQ:TTRX) Given Average Rating of "Hold" by BrokeragesMarket Beat·Sep 14 at 06:14 PMTTRX-5.81%BLK+1.20%
Turn Therapeutics Inc (TTRX) was downgraded to a Sell Rating at WBB SecuritiesTip Ranks·Sep 14 at 03:35 PMTTRX-5.81%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Sep 11 at 09:06 PMTTRX-5.81%XAIR-10.09%
Turn Therapeutics to present at Stifel virtual immunology and inflammation forumPUBT·Sep 10 at 12:05 PMTTRX-5.81%
Turn Therapeutics names former CDC director Robert Redfield chief scientific officerPUBT·Sep 9 at 12:01 PMTTRX-5.81%
Turn Therapeutics says mouse study shows GX-03 cuts dermatitis severity 66%PUBT·Aug 20 at 12:03 PMTTRX-5.81%
Turn Therapeutics sells 135,000 shares in private placement for $1.35 millionPUBT·Aug 17 at 08:16 PMTTRX-5.81%
Ladenburg Thalmann & Co. Keeps Their Buy Rating on Turn Therapeutics Inc (TTRX)Tip Ranks·Aug 13 at 04:35 PMTTRX-5.81%
Turn Therapeutics releases corporate deck outlining GX-03 topical immunomodulator program for atopic dermatitisPUBT·Jul 28 at 12:09 PMTTRX-5.81%
